WithdrawnPhase 4NCT02734186
Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis
Studying Schistosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Amy D Klion, M.D.National Institute of Allergy and Infectious Diseases (NIAID)
- Intervention
- Praziquantel(drug)
- Eligibility
- 14-80 years · All sexes
- Timeline
- 2016 – 2018
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02734186 on ClinicalTrials.govOther trials for Schistosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06698510Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention StudyPeter Steinmann
- RECRUITINGNANCT06873308Assessment of Infection Activity in Travelers and Migrants Diagnosed With Chronic SchistosomiasisIRCCS Sacro Cuore Don Calabria di Negrar